Tvardi Therapeutics is trading 8.06% higher at $1.03, with no fresh company-specific announcement identified to explain the November 9 move. - The move extends the 10.79% gain recorded on November 6. - The company’s investor-relations page lists October 14 as its latest release. - Major U.S. indexes are higher, which may support broader risk appetite but does not establish a direct cause. Today’s trading volume was not provided, so activity cannot be assessed.